Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 686.5 | 60 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 755.0 | 54 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 917.0 | 77 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1098.5 | 80 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 793.0 | 61 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1191.5 | 64 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1602.0 | 54 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 2381.0 | 64 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1547.0 | 73 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1296.0 | 72 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1673.0 | 61 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 2520.5 | 50 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1164.5 | 72 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 1315.0 | 62 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1028.5 | 48 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1394.0 | 67 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 713.0 | 57 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 979.5 | 58 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1241.0 | 73 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1194.0 | 57 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 859.0 | 56 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1202.0 | 75 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1474.0 | 71 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | VEGF | 1921.0 | 67 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 760.0 | 59 |